MIM
Monashee Investment Management Portfolio holdings
AUM
$190M
This Quarter Return
+2.26%
1 Year Return
+42.84%
3 Year Return
+185.9%
5 Year Return
+237.5%
10 Year Return
+2,730.86%
AUM
$773M
AUM Growth
+$773M
(-8.5%)
Cap. Flow
-$77.8M
Cap. Flow
% of AUM
-10.06%
Top 10 Holdings %
Top 10 Hldgs %
77.44%
Holding
147
New
42
Increased
10
Reduced
17
Closed
69
Top Buys
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
$11.8M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
$11.3M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
$11.2M |
| 4 |
Birkenstock
BIRK
|
$10.9M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
$10M |
Top Sells
| 1 |
AB InBev
BUD
|
$16.4M |
| 2 |
SharkNinja
SN
|
$14.8M |
| 3 |
Kaspi.kz JSC
KSPI
|
$11.2M |
| 4 |
ODDITY Tech
ODD
|
$8.91M |
| 5 |
GE Aerospace
GE
|
$8.43M |
Sector Composition
| 1 | Healthcare | 6.59% |
| 2 | Technology | 4.5% |
| 3 | Industrials | 3.66% |
| 4 | Financials | 3.35% |
| 5 | Consumer Discretionary | 2.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Evolus
EOLS
$477M
| – | – |
-150,000
| Closed | -$2.1M |
|
127
Essential Properties Realty Trust
EPRT
$6.13B
| – | – |
-125,000
| Closed | -$3.33M |
|
128
EyePoint Pharmaceuticals
EYPT
$827M
| – | – |
-100,000
| Closed | -$2.07M |
|
129
Five Star Bancorp
FSBC
$693M
| – | – |
-25,000
| Closed | -$563K |
|
|
130
GE Aerospace
GE
$293B
| – | – |
-48,000
| Closed | -$8.43M |
|
131
GE HealthCare
GEHC
$33B
| – | – |
-30,000
| Closed | -$2.73M |
|
132
Werewolf Therapeutics
HOWL
$62.6M
| – | – |
-890,000
| Closed | -$5.77M |
|
133
Ichor Holdings
ICHR
$552M
| – | – |
-122,960
| Closed | -$4.75M |
|
134
Immunome
IMNM
$892M
| – | – |
-132,500
| Closed | -$3.27M |
|
135
Immunovant
IMVT
$2.91B
| – | – |
-100,000
| Closed | -$3.23M |
|
136
Keurig Dr Pepper
KDP
$39.5B
| – | – |
-10,000
| Closed | -$307K |
|
137
Kinetik
KNTK
$2.55B
| – | – |
-125,000
| Closed | -$4.98M |
|
138
Korro Bio
KRRO
$245M
| – | – |
-55,364
| Closed | -$4.98M |
|
|
139
Kaspi.kz JSC
KSPI
$17.2B
| – | – |
-87,000
| Closed | -$11.2M |
|
140
Milestone Pharmaceuticals
MIST
$151M
| – | – |
-500,000
| Closed | -$895K |
|
141
MeridianLink
MLNK
$1.47B
| – | – |
-80,000
| Closed | -$1.5M |
|
142
Mersana Therapeutics
MRSN
$34.8M
| – | – |
-310,000
| Closed | -$1.39M |
|
143
Matador Resources
MTDR
$6.09B
| – | – |
-60,000
| Closed | -$4.01M |
|